We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Roche and French drugmaker Transgene announced that they have entered into an exclusive worldwide collaboration agreement to develop and commercialize products from Transgene's line of vaccines against human papillomavirus (HPV)-mediated diseases.
Benda Pharmaceutical announced that, through its Chinese subsidiary Hubei Tongji Benda Ebei Pharmaceutical, it has acquired majority ownership of Shenzhen SiBiono GeneTech for approximately $7.7 million.
Nigeria's National Agency for Food and Drug Administration and Control (NAFDAC) has been cracking down on counterfeit drugs in Nigeria, the U.N. Integrated Regional Information Networks (IRIN) reports.
The FDA has ordered companies to stop manufacturing unapproved suppository products containing trimethobenzamide hydrochloride because the drugs lack proof of efficacy.
Lundbeck Pharmaceuticals Italy and MultiCell Technologies have entered into a long-term agreement for the supply of one of the active components of MCT-125, MultiCell's investigational drug for the treatment of chronic fatigue in patients with multiple sclerosis (MS).
The World Health Organization (WHO) and Abbott Laboratories have agreed on an approach to making the HIV drug Kaletra available in the developing world, the company announced.
The U.S. FDA announced it has granted tentative approval to generic abacavir sulfate tablets, 300 mg, manufactured by Matrix Laboratories, under the expedited review provisions developed for the President's Emergency Plan for AIDS Relief (PEPFAR).
VaxGen announced last week it has signed a settlement agreement with the U.S. HHS that releases both parties from all liabilities associated with the company's government contracts to develop and deliver a next-generation anthrax vaccine.
Schering-Plough announced that PEG-Intron has been approved by the Chinese State Food and Drug Administration (SFDA)for the treatment of chronic hepatitis B, the most prevalent infectious disease in China, according to the company.